Diagnostic Performance of PET or PETCT with Different Radiotracers in Patients with Suspicious Lung Cancer or Pleural Tumours according to Published Meta-Analyses
المؤلفون المشاركون
Treglia, Giorgio
Lococo, Filippo
Muoio, Barbara
Chiappetta, Marco
Nachira, Dania
Petracca Ciavarella, Leonardo
Margaritora, Stefano
المصدر
Contrast Media & Molecular Imaging
العدد
المجلد 2020، العدد 2020 (31 ديسمبر/كانون الأول 2020)، ص ص. 1-7، 7ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2020-04-25
دولة النشر
مصر
عدد الصفحات
7
التخصصات الرئيسية
الملخص EN
Purpose.
Several meta-analyses have reported data about the diagnostic performance of positron emission tomography or positron emission tomography/computed tomography (PET or PET/CT) with different radiotracers in patients with suspicious lung cancer (LC) or pleural tumours (PT).
This review article aims at providing an overview on the recent evidence-based data in this setting.
Methods.
A comprehensive literature search of meta-analyses published in PubMed/MEDLINE and Cochrane Library database from January 2010 through March 2020 about the diagnostic performance of PET or PET/CT with different radiotracers in patients with suspicious LC or PT was performed.
This combination of keywords was used: (A) “PET” OR “positron emission tomography” AND (B) “lung” OR “pulmonary” OR “pleur∗” AND (C) meta-analysis.
Only meta-analyses on PET or PET/CT in patients with suspicious LC or PT were selected.
Results.
We have summarized the diagnostic performance of PET or PET/CT with fluorine-18 fluorodeoxyglucose (18F-FDG) and other radiotracers taking into account 17 meta-analyses.
Evidence-based data demonstrated a good diagnostic performance of 18F-FDG PET or PET/CT for the characterization of solitary pulmonary nodules (SPNs) or pleural lesions with overall higher sensitivity than specificity.
Evidence-based data do not support the routine use of dual time point (DTP) 18F-FDG PET/CT or fluorine-18 fluorothymidine (18F-FLT) PET/CT in the differential diagnosis of SPNs.
Even if 18F-FDG PET/CT has high sensitivity and specificity as a selective screening modality for LC, its role in this setting remains unknown.
Conclusions.
Evidence-based data about the diagnostic performance of PET/CT with different radiotracers for suspicious LC or PT are increasing, with good diagnostic performance of 18F-FDG PET/CT.
More prospective multicenter studies and cost-effectiveness analyses are warranted.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Lococo, Filippo& Muoio, Barbara& Chiappetta, Marco& Nachira, Dania& Petracca Ciavarella, Leonardo& Margaritora, Stefano…[et al.]. 2020. Diagnostic Performance of PET or PETCT with Different Radiotracers in Patients with Suspicious Lung Cancer or Pleural Tumours according to Published Meta-Analyses. Contrast Media & Molecular Imaging،Vol. 2020, no. 2020, pp.1-7.
https://search.emarefa.net/detail/BIM-1139258
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Lococo, Filippo…[et al.]. Diagnostic Performance of PET or PETCT with Different Radiotracers in Patients with Suspicious Lung Cancer or Pleural Tumours according to Published Meta-Analyses. Contrast Media & Molecular Imaging No. 2020 (2020), pp.1-7.
https://search.emarefa.net/detail/BIM-1139258
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Lococo, Filippo& Muoio, Barbara& Chiappetta, Marco& Nachira, Dania& Petracca Ciavarella, Leonardo& Margaritora, Stefano…[et al.]. Diagnostic Performance of PET or PETCT with Different Radiotracers in Patients with Suspicious Lung Cancer or Pleural Tumours according to Published Meta-Analyses. Contrast Media & Molecular Imaging. 2020. Vol. 2020, no. 2020, pp.1-7.
https://search.emarefa.net/detail/BIM-1139258
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1139258
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر